Search results
Results from the WOW.Com Content Network
This is an accepted version of this page This is the latest accepted revision, reviewed on 13 February 2025. African-American woman (1920–1951), source of HeLa immortal cell line "Lacks" redirects here. For other uses, see Lack. Henrietta Lacks Lacks c. 1945–1951. Born Loretta Pleasant (1920-08-01) August 1, 1920 Roanoke, Virginia, U.S. Died October 4, 1951 (1951-10-04) (aged 31) Baltimore ...
The Immortal Life of Henrietta Lacks is a 2017 American drama television film directed by George C. Wolfe and starring Oprah Winfrey and Rose Byrne.It is based on the book of the same name by Rebecca Skloot and documents the story of Henrietta Lacks, who was diagnosed with cervical cancer in the 1950s, and whose cancer cells (later known as HeLa) would change the course of cancer treatment.
The book is about Henrietta Lacks and the immortal cell line, known as HeLa, that came from Lacks's cervical cancer cells in 1951. Skloot became interested in Lacks after a biology teacher referenced her but knew little about her. Skloot began conducting extensive research on her and worked with Lacks' family to create the book.
The remarkable science involved — and the impact on the Lacks family, some of whom had chronic illnesses and no health insurance — were documented in a bestselling book by Rebecca Skloot ...
The estate of Henrietta Lacks filed a lawsuit in Maryland federal court on Thursday accusing biopharmaceutical company Ultragenyx Pharmaceutical of unlawfully profiting from cells that were taken ...
As documented in the bestselling book, “The Immortal Life of Henrietta Lacks,” Lacks’ history with Johns Hopkins is a controversial one. After seeking treatment at the institution’s ...
He was the initial treating physician of Henrietta Lacks when she presented to Johns Hopkins with cancer in 1951. [3] Jones took a biopsy of Lacks's tumor and sent samples to his laboratory colleagues. The cells, later known as HeLa cells, grew at an astonishing rate in the lab and were shipped and sold to researchers for various purposes.
For premium support please call: 800-290-4726 more ways to reach us